Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia
AstraZeneca
AstraZeneca
National Cancer Institute (NCI)
Technical University of Madrid
Children's National Research Institute
Assistance Publique - HĂ´pitaux de Paris
National Institutes of Health Clinical Center (CC)
MPN Research Foundation
Hospital Italiano de Buenos Aires
University Health Network, Toronto
Prisma Health-Upstate
Assistance Publique - HĂ´pitaux de Paris
CNAO National Center of Oncological Hadrontherapy
University Hospital, Geneva
Sanford Health
Associazione Angela Serra per la ricerca sul cancro
University Hospital Tuebingen
University Hospital Heidelberg
Istituto Ortopedico Rizzoli
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Munich Leukemia Laboratory
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
xCures
University Hospital Tuebingen
Universitätsklinikum Hamburg-Eppendorf
University Hospital Tuebingen
Gradalis, Inc.
University Hospital Tuebingen
Hospices Civils de Lyon
Klus Pharma Inc.
Gradalis, Inc.
Istituto Ortopedico Rizzoli
Xperiome
Associazione Angela Serra per la ricerca sul cancro
Associazione Angela Serra per la ricerca sul cancro
FDA Office of Orphan Products Development
FDA Office of Orphan Products Development
FDA Office of Orphan Products Development
FDA Office of Orphan Products Development
FDA Office of Orphan Products Development
FDA Office of Orphan Products Development
FDA Office of Orphan Products Development
FDA Office of Orphan Products Development
FDA Office of Orphan Products Development
Office of Rare Diseases (ORD)
National Center for Research Resources (NCRR)
Office of Rare Diseases (ORD)
National Center for Research Resources (NCRR)
National Center for Research Resources (NCRR)
Office of Rare Diseases (ORD)
Office of Rare Diseases (ORD)